Home Cart 0 Sign in  

[ CAS No. 33332-29-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 33332-29-5
Chemical Structure| 33332-29-5
Structure of 33332-29-5 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 33332-29-5 ]

Related Doc. of [ 33332-29-5 ]

Alternatived Products of [ 33332-29-5 ]
Product Citations

Product Details of [ 33332-29-5 ]

CAS No. :33332-29-5 MDL No. :MFCD03423596
Formula : C4H4ClN3 Boiling Point : -
Linear Structure Formula :- InChI Key :HWCKAMAVEWVBDO-UHFFFAOYSA-N
M.W : 129.55 Pubchem ID :12808419
Synonyms :

Calculated chemistry of [ 33332-29-5 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 8
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 31.45
TPSA : 51.8 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.61 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.17
Log Po/w (XLOGP3) : 0.67
Log Po/w (WLOGP) : 0.72
Log Po/w (MLOGP) : -0.45
Log Po/w (SILICOS-IT) : 0.98
Consensus Log Po/w : 0.62

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.62
Solubility : 3.11 mg/ml ; 0.024 mol/l
Class : Very soluble
Log S (Ali) : -1.33
Solubility : 6.0 mg/ml ; 0.0463 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.87
Solubility : 1.74 mg/ml ; 0.0135 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.01

Safety of [ 33332-29-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 33332-29-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 33332-29-5 ]

[ 33332-29-5 ] Synthesis Path-Downstream   1~2

  • 2
  • [ 33332-29-5 ]
  • [ 19745-07-4 ]
YieldReaction ConditionsOperation in experiment
15% With hydrogenchloride; sodium nitrite; In water; at -10 - 20℃; for 4h; Step 2: Synthesis of 2,5-dichloropyrazine To a stirred solution of 5-chloropyrazin-2-amine (1 g, 7.751 mmol) in conc. HCl (10 mL) was added aq. solution sodium nitrite (1.1 g, 15.89 mmol) at -10° C. over a period of 1 h, stirred for 1 h 0° C. and then at RT for 2 h. Progress of reaction was monitored by TLC. After reaction completion reaction mass neutralised with 50percent NaOH solution and extracted with DCM. The organic layer was dried over sodium sulphate and concentrated under reduced pressure. Crude was purified by silica gel (100-200 mesh) column chromatography using 2percent ethyl acetate in hexane as eluent to yield 2,5-dichloropyrazine (0.59 g, 15percent) as colourless oil. MS: 184.1 [M-1]
With tert.-butylnitrite; copper(l) chloride; copper dichloride; In acetonitrile; at -10 - 65℃; for 3h; Step 2: Preparation of 2,5-dichloropyrazine; 5-Chloropyrazin-2-amine (5.0 g, 38.6 mmol) was dissolved in acetonitrile (77 ml) under a balloon of N2. The copper(I) chloride (5.7 g, 57.9 mmol) and copper(ET) chloride (7.8 g, 57.9 mmol) were added and the slurry cooled to -1O 0C with an ice:acetone bath. t-Butyl nitrite (9.15g, 89 mmol, 90percent) was added dropwise and the solution allowed to warm to RT. The solution was stirred for 30 minutes until rapid gas evolution ceased. The mixture was heated to 65 0C for 2.5 hours. The mixture was cooled to RT and filtered through a 1.5 inch pad of celilte packed into a 465 ml frit. The pad was washed with DCM (200 ml x 4), the wash fractions containing the desired material combined, filtered, and concentrated in vacuo. <n="55"/>The residue was purified by chromatography on silica gel with 2percent etheI.euro.pentane to yield the title compound.
With hydrogenchloride; sodium nitrite; In water; at 0 - 20℃; for 3h; Step 2: 2,5-Dichloropyrazine; 5-Chloro-2-pyrazinamine (product of E1, step 1) (2.41g, 18.6mmole) was dissolved in concentrated hydrochloric acid (24ml), cooled in an ice-acetone bath and treated with a solution of sodium nitrite (2.63g, 38.1 mmole) in water (1 8ml) dropwise over a period of 1 hour. The mixture was cooled in an ice-water bath and left to stir for 1 hour. The mixture was allowed to warm to room temperature over 1 hour, neutralised by addition of sodium hydroxide solution (2M) and extracted with dichloromethane ( x 4). The dichloromethane layers were combined, dried under magnesium sulfate and evaporated in vacuo. The resulting residue was purified by column chromatography (1: 9 ethyl acetate: pentane) to afford the title compound (0.33g). 1H NMR (CDCl3) 8.40 (2H, s).
With hydrogenchloride; sodium nitrite; In water; at 0 - 20℃; for 3h;ice-acetone bath; 5-CHLORO-2-PYRAZINAMINE (D47, Step 1) (2.41 g, 18.6 MMOL) was dissolved in concentrated hydrochloric acid (24 ML), cooled in an ice-acetone bath and treated with a solution of sodium nitrite (2.63 g, 38.1 MMOL) in water (18 ML) dropwise over a period of 1 hour. The mixture was cooled in an ice-water bath and left to stir for 1 hour. The mixture was allowed to warm to room temperature over 1 hour, neutralised by addition of sodium hydroxide solution (2M) and extracted with dichloromethane. The DICHLOROMETHANE layers were combined, dried under magnesium sulfate and evaporated in vacuo. The resulting residue was purified by column chromatography eluting with a mixture of ethyl acetate: pentane (1: 9) to afford the title compound (0.33 g);'H NMR (CDCI3) 8.40 (2H, s).
With hydrogenchloride; sodium nitrite; In water; at 0 - 20℃; for 4h;Ic; Description 5 2,5-Dichloropyrazine (D5); 5-Chloro-2-pyrazinamine (D4) (753 mg, 5.81 mmol) was dissolved in concentrated hydrochloric acid (8 ml), cooled in an ice-acetone bath and treated with a solution of sodium nitrite (822 mg, 11.9 mmol) in water (6 ml) dropwise over a period of 1 hour. The mixture was transferred to an ice-water bath and left to stir for 1 hour. The mixture was allowed to warm to room temperature over 2 hours, neutralised by addition of an aqueous 50percent sodium hydroxide solution and extracted with dichloromethane (x 4). The dichloromethane layers were combined, dried under magnesium sulfate and evaporated. The resulting residue was purified by Biotage column chromatography eluting with 10percent ethyl acetate in pentane to afford the title compound (112 mg). 1H NMR (CDCI3) 8.40 (2H, s).

Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Functional Groups of
[ 33332-29-5 ]

Chlorides

Chemical Structure| 14508-49-7

[ 14508-49-7 ]

2-Chloropyrazine

Similarity: 0.78

Chemical Structure| 212779-21-0

[ 212779-21-0 ]

2-Amino-3-bromo-6-chloropyrazine

Similarity: 0.75

Chemical Structure| 76537-18-3

[ 76537-18-3 ]

3-Bromo-5-chloropyrazin-2-amine

Similarity: 0.75

Chemical Structure| 14399-37-2

[ 14399-37-2 ]

3,6-Dichloropyrazin-2-amine

Similarity: 0.73

Chemical Structure| 173253-42-4

[ 173253-42-4 ]

2-Amino-5-bromo-6-chloropyrazine

Similarity: 0.73

Amines

Chemical Structure| 212779-21-0

[ 212779-21-0 ]

2-Amino-3-bromo-6-chloropyrazine

Similarity: 0.75

Chemical Structure| 76537-18-3

[ 76537-18-3 ]

3-Bromo-5-chloropyrazin-2-amine

Similarity: 0.75

Chemical Structure| 873-42-7

[ 873-42-7 ]

2-Amino-3,5-dichloropyrazine

Similarity: 0.73

Chemical Structure| 14399-37-2

[ 14399-37-2 ]

3,6-Dichloropyrazin-2-amine

Similarity: 0.73

Chemical Structure| 173253-42-4

[ 173253-42-4 ]

2-Amino-5-bromo-6-chloropyrazine

Similarity: 0.73

Related Parent Nucleus of
[ 33332-29-5 ]

Pyrazines

Chemical Structure| 14508-49-7

[ 14508-49-7 ]

2-Chloropyrazine

Similarity: 0.78

Chemical Structure| 212779-21-0

[ 212779-21-0 ]

2-Amino-3-bromo-6-chloropyrazine

Similarity: 0.75

Chemical Structure| 76537-18-3

[ 76537-18-3 ]

3-Bromo-5-chloropyrazin-2-amine

Similarity: 0.75

Chemical Structure| 14399-37-2

[ 14399-37-2 ]

3,6-Dichloropyrazin-2-amine

Similarity: 0.73

Chemical Structure| 173253-42-4

[ 173253-42-4 ]

2-Amino-5-bromo-6-chloropyrazine

Similarity: 0.73

; ;